secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2025-08-27T23:59:59+00:00
Accession:  0001193125-25-189169
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma stockholders approve reverse stock split, equity plan amendment; files $119.7M ATM prospectus
--------------------------------------------------------------------------------

- Stockholders approved reverse stock split in range 1-for-5 to 1-for-30; board to determine ratio.
- Approved amendment to 2021 equity plan to add 25M shares and reduce annual evergreen from 5% to 4%.
- Approved issuance of common stock underlying outstanding warrants for Nasdaq Listing Rule 5635(d) compliance.
- Filed prospectus supplement to register up to $119.7M of common stock for ATM offering through Stifel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525189169/0001193125-25-189169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525189169/d24419d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-189169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer